MedPath
FDA Approval

Adenosine

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Gland Pharma Limited
DUNS: 918601238
Effective Date
December 4, 2017
Labeling Type
Human Prescription Drug Label
Adenosine(3 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Gland Pharma Limited

Gland Pharma Limited

918601238

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Adenosine

Product Details

NDC Product Code
68083-101
Application Number
ANDA077283
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
December 4, 2017
sodium chlorideInactive
Code: 451W47IQ8XClass: IACT
waterInactive
Code: 059QF0KO0RClass: IACT
AdenosineActive
Code: K72T3FS567Class: ACTIBQuantity: 3 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath